Latest News about GKOS
Recent news which mentions GKOS
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
December 06, 2024
From Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December 02, 2024
From Benzinga
From Benzinga
Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds
November 05, 2024
From Benzinga
From Benzinga
Tickers
GKOS
From InvestorPlace
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
From InvestorPlace
From Benzinga
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
May 02, 2024
From Benzinga
From Benzinga
Tickers
GKOS
From InvestorPlace
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
From Benzinga
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
February 22, 2024
From Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
From Benzinga
Glaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst
December 21, 2023
Tickers
GKOS
From Benzinga
From Benzinga
iDoseTR Approval Sets Stage for Glaukos' Game-Changing Product, Surpassing Market Expectations, Says Analyst
December 15, 2023
Tickers
GKOS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.